Our Work
Menstrual Hygiene Management
Countries: Ethiopia - India - Kenya
Understand the menstrual journey of Adolecent Girls and Young Women (AGYW), the role of their ecosytem of influencers (parents, siblings (sisters), teachers and Community Health Workers (CHWs)), what AGYW use, the barriers and what they need
Research Concept Creation
Countries: Sub-Saharan Africa (SSA)
Exploring and ideating research concepts and uncovering research gaps in the Multipurpose Prevention Technologies (MPT) / HIV / Family Planning (FP) prevention arena
The Contraceptive Vaginal Ring (CVR)
Countries: Kenya - Nigeria
Understand the appeal of Annovera - Contraceptive Vaginal Ring (CVR), develop and test visual concepts for the CVR as well as Consumer Target Product Profiles (CTPPs) and forecast its potential market impact. Refine CTPPs and visual concepts post qualitative and quantitative phases
MPTs - Strategy, Research & Product Development
Countries: EU, SSA + USA
Understand the current landscape for research and product development in Multipurpose Prevention Technologies (MPT), HIV and Family Planning (FP) arenas; appreciate limitations / gaps and where the area could be strengthened
Strategic Framework development for Prevention and MPTs
Countries: EU, SSA + USA
Support the design of a Strategic Framework Evaluation (SFE) for antiretroviral prevention (ARV) products and Multipurpose Prevention Technologies (MPTs)
HIV Prevention Products - Dapirivine Ring & Oral Truvada
Countries: South Africa
Understand the end-user appeal of HIV prevention products both generally and with focus on the Dapirivine Ring and Oral Truvada, the push and pull and eco-system of using prevention products, critical message hooks, category surroundings and likelihood to try. Refine CTPPs post qualitative and quantitative phases
HIV Prevention Products - implant, monthly pill and broadly neutralising Antibodies (bnAbs)
Countries: Kenya - South Africa
Understand the lives of women and their eco-system (including community leaders/members, family, partners, friends) around health, relationships, HIV and HIV prevention. Appreciate the appeal of HIV prevention methods, value proposition, product perception, critical hooks, barriers, and likelihood to try. Refine CTPPs post qualitative phase
The Contraceptive Injections (DMPA + DMPA-SC)
Countries: Nigeria - Uganda
Understand women's and partners' contraceptive injection experience (current users, those who have stopped using, naive users). Uncover the appeal and perceived barriers of the DMPA and DMPA-sub cutaneous, Consumer Target Product Profiles (CTPPs). Appreciate the impact and perception of side-effects through human-centred design exercises. Understand willingness to try and impact of attribute comparisons across the discussion through Routes2Results' (R2R) trademarked behavioural economics-based exercise 'Quickfires'. Refine CTPPs post qualitative and quantitative phases. Quantitatively test various profiles, appeal, and forecast likelihood of trial/use and impact on contraceptive market
The Contraceptive Intrauterine System (IUS)
Countries: Kenya - Nigeria
Understand appeal of the IUS with end-users and healthcare providers (HCPs) - looking at Consumer Target Product Profiles (CTPP). Understand the value proposition of the IUS, likelihood to try and why, as well as appreciating the most impactful messaging set. Refine CTPP post both qualitative and quantitative phases
Mental Health - 2nd Generation Anti-Psychotics
Countries: Rwanda
Understand the patient journey from the perception of critical healthcare providers (HCPs), check for consistencies and differences between HCPs and patients. Understand the current treatment pathway, its benefits, and opportunities to strengthen skills. Test / check 2nd generation TPP for appeal, resonance, importance and likely impact. Support the creation of an HCP-focused support program
Vaccine Linkage Strategy and Implementation
Countries: Nepal
A review of the MR-SIA campaign in Nepal from all stakeholders, from on-the-ground implementers at health facility and community levels (vaccinators and FCHVs) to federal functionaries involved in the strategic planning, facilitating, and monitoring of the campaign. Understand how, and how well, the program ran, how it reached the under-immunised populations, what could have been improved, needs created from the program, and needs met by the program
Contraceptive in Development: Monthly Oral Contraceptive
Countries: Bangladesh - Senegal - Zimbabwe
Provide feedback on product-based attributes and determine the critical attributes that affect user experience, and utilize this to inform early technical design. Understand profile impact, refine messaging post qualitative and quantitative phases, and check appeal
Contraceptive in Development: Micro Array Patches (MAPs)
Countries: Ghana - Kenya - Uganda
Gain an understanding of the Micro Array Patch (MAP) product appeal by its product characteristics, design/look and value proposition. A deeper understanding of potential biases, barriers, or unforeseen design issues with the product. Specific, actionable product design iteration and development recommendations. Quick-fire attribute survey findings based on attributes of the various MAPs. Quantitative Max Diff exercise and motivation to use analysis, and the relative appeal of each attribute
Strengthening the accessibility, acceptability, and availability of PEP
Countries: Kenya, Nigeria, Zimbabwe
Uncover End-user (Young Women Men and Key populations) and provider perspectives on current behaviors towards WHO PEP pathway (awareness, experiences, barriers and channels) with a view to gauging how to best broaden access and expansion of PEP packages, additional / related services (e.g. PrEP).
Drug acceptability – blocking the bitter taste of medication
Countries: Kenya, Nigeria, Zimbabwe
Understanding values and preferences of End-Users and Providers around blocking bitter taste to improve pediatric (US: and Geriatric) drug acceptability.
